About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Seminars in Thrombosis and Hemostasis
›
Top Articles
Seminars in Thrombosis and Hemostasis
Hematology
5.3
(top 2%)
Impact Factor
5.7
(top 2%)
extended IF
107
(top 3%)
H-Index
777
authors
3.5K
papers
91.6K
citations
5.6K
citing journals
31.3K
citing authors
Most Cited Articles of Seminars in Thrombosis and Hemostasis
Title
Year
Citations
A critical reappraisal of the bleeding time
1990
590
Blood rheology and hemodynamics
2003
573
Fibrinogen as a hemostatic agent
2012
564
Hyperhomocysteinemia and venous thromboembolism
2006
541
Description of an in vitro platelet function analyzer--PFA-100
1995
392
PFA-100 system: a new method for assessment of platelet dysfunction
1998
367
Platelet dysfunction in renal failure
2004
312
Platelets: physiology and biochemistry
2005
312
Hemostasis during normal pregnancy and puerperium
2003
302
Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon
1999
275
Hemostasis changes during cardiopulmonary bypass surgery
1985
270
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis
2005
266
Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis
1995
266
Heterogeneity of the tumor vasculature
2010
250
Pathways and regulation of homocysteine metabolism in mammals
2000
247
Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock
1998
238
Clinical utility of the PFA-100
2008
235
Microparticles in cancer
2010
228
Platelets and angiogenesis in malignancy
2004
228
Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis
1997
226
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists
2005
225
Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity
2005
222
Pathophysiology of the thrombophilic state in the cancer patient
1999
209
Large platelets circulate in an activated state in diabetes mellitus
1991
204
Regulation of thrombin generation and functions
1988
204
previous
2005
2006
2007
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.